Bone Morphogenic Proteins: Future Therapeutic Applications

Introduction

Stimulating the human body to generate and repair bone, reliably and quickly has been one of the greatest challenges of orthopedic research. Traditional procedures like bone grafting techniques do not always result in successful bone fusion. Innovations in this field have revealed that a genetically produced protein (Bone Morphogenic Protein (BMP)) has the ability to stimulate patient's own cells to generate bone. These proteins hold many advantages in the treatment of bone fractures and bone defects. Currently, two of these proteins BMP-2 and BMP-7, are approved for clinical use in non-union, tibial fractures and spinal fusion procedures. Extensive researches on BMPs promise new and distinct clinical applications in the future. Percutaneous injections are at present the focal point of research for the applications of BMPs, while these are further being considered for engineering the regeneration of skeletal parts.

Scope

- The study discusses the future therapeutic applications of bone morphogenic proteins (BMP), listing out BMPs and its functions.
- It discusses the global BMP market, based on revenue and procedure units, and geography, during 2009-2016.
- It also briefs about BMP market dynamics, overlooking the drivers and restraints of the BMP market.
- Product portfolio of the BMP market is also discussed in the study.

Highlights

Reasons to buy

- Develop business strategies with the help of specific insights from GlobalData on key events within the medical equipment industry.
- Gain a strong understanding and analyze major trends in the Indian medical equipment industry
- Identify growth opportunities within the medical equipment industry in India

Report Highlights

[Fade out the market survey infos]

TABLE OF CONTENTS

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 GlobalData Market Analysis Alert 6
2.1 Summary 6
3 Bone Morphogenic Proteins: Future Therapeutic Applications 7
3.1 Summary 7
3.2 Overview 7
3.3 Bone Morphogenic Proteins Market Characterization 8
3.3.1 Market Overview 8
3.3.2 Bone Morphogenic Proteins Cross Country Analysis 10
3.3.3 Bone Morphogenic Proteins Market Dynamics 12
3.3.3.1 Market Drivers 12
3.3.3.2 Market Restraints 12
3.3.4 Product Portfolio 13
3.4 Future Therapeutic Applications of Bone Morphogenic Proteins 14
3.4.1 Percutaneous Injections 14
3.4.2 Bone Morphogenic Proteins for Tissue Engineering 14
3.5 Future Outlook 15
4 Appendix 16
4.1 GlobalData Research Methodology 16
4.2 Secondary Research 17
4.3 Primary Research 18
4.4 Models 18
4.5 Forecasts 19
4.6 Expert Panel Validation 19
4.7 Currency Conversion 20
4.8 Contact Us 21
4.9 Disclaimer 21
[Fade out table of contents]

LIST OF TABLES

1.1 List of Tables
Table 1: List of BMPs and Their Functions 7
Table 2: Bone Morphogenic Proteins, Global, Revenue ($m), Procedure Units, 2009-2016 9
Table 3: Bone Morphogenic Proteins, Cross Country Analysis 11
Table 4: Marketed Products 13
Table 5: Pipeline Products 13
Table 6: USD to Local Currency, Average Exchange Rate 2008 20
LIST OF FIGURES

1.2 List of Figures
Figure 1: Bone Morphogenic Proteins, Global, Revenue and Procedure Units, 2009-2016 8
Figure 2: Bone Morphogenic Proteins, Cross Country Analysis 10
Figure 3: GlobalData Methodology 17
[Fade out list of tables / figures]